Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

Gastroenterology

Volumn 124, Issue 1, 2003, Pages 147-159

  Yang, Changqing ^a   Zeisberg, Michael ^a   Mosterman, Barbara ^a   Sudhakar, Akulapalli ^a   Yerramalla, Udaya ^a   Holthaus, Kathryn ^a   Xu, Lieming ^b   Eng, Francis ^b   Afdhal, Nezam ^a   Kalluri, Raghu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; INTEGRIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEALTH; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STELLATE CELL;

EID: 0037221910     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50012     Document Type: Article

References (63)

1. U.S. Department of Health and Human Services. National Vital Statistics Reports 2000;48:51-53.
2. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998;29:836-847.
3. Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 2001;5:315-334, v-vi.
4. Hwang YT, Chen PJ, Kao JH, Wang TD, Wang HH, Chu JS, Su U, Chen DS. Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis. Liver 1996;16:283-287.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
6. Benyon RC, Arthur MJ. Mechanisms of hepatic fibrosis. J Pediatr Gastroenterol Nutr 1998;27:75-85.
7. Rojkind M. The extracellular matrix. In: Arias I, Popper D, Shafritz DA. The Liver Biology and Pathobiology. 1st Ed. New York: Raven, 1982:537-548.
8. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990;10:30-46.
9. Gressner AM, Lahme B, Brenzel A. Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells. Hepatology 1995;22:1507-1518.
10. Neubauer K, Saile B, Ramadori G. Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 2001;15:187-193.
11. Yoshida T, Adachi E, Nigi H, Fujii S, Yanagi M. Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CCI4 in cynomolgus monkeys. Pathology 1999;31:29-35.
12. Clark SA, Angus HB, Cook HB, George PM, Oxner RB, Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet 1988;2:1225-1227.
13. Eng FJ, Friedman SL. Transcriptional regulation in hepatic stellate cells. Semin Liver Dis 2001;21:385-395.
14. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. An immortalized rat liver stellate cell line (HSC-T6): A new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000;41:882-893.
15. Matsuura T, Hasumura S, Nagamori S, Murakami K. Retinol esterification activity contributes to retinol transport in stellate cells. Cell Struct Funct 1999;24:111-116.
16. Friedman SL. The virtuosity of hepatic stellate cells. Gastroenterology 1999;117:1244-1246.
17. Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy. J Gastroenterol Hepatol 1999;14:618-633.
18. Bissell DM. Hepatic fibrosis as wound repair: A progress report. J Gastroenterol 1998;33:295-302.
19. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999;19:129-140.
20. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, zum Buschenfelde KH, Blessing M. TGF-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999;276:G1059-G1068.
21. Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, Ramadori G. Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol 1999;31:692-702.
22. Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001;34:859-867.
23. Yokoi Y, Nakamura S, Serizawa A, Nishiyama R, Nishiwaki Y, Suzuki S, Baba S. Role of endogenous endothelin in renal impairment during acute liver rejection in rats. Transplant Proc 1994;26:904-906.
24. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol 2001;281:F513-F521.
25. George J, Wang SS, Sevcsik AM, Sanicola M, Cate RL, Koteliansky VE, Bissell DM. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. Am J Pathol 2000;156:115-124.
26. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455.
27. Kim Y, Ratziu V, Choi SG, Lalazar A, Theiss G, Dang Q, Kim SJ, Friedman SL. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998;273:33750-33758.
28. Nieto N, Friedman SL, Greenwel P, Cederbaum AI. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999;30:987-996.
29. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology 1992;15:234-243.
30. Arthur MJ, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992;287:701-707.
31. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000;275:1209-1215.
32. Sudhakar A, Ramachandran A, Ghosh S, Hasnain SE, Kaufman RJ, Ramaiah KV. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000;39:12929-12938.
33. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002;295:140-143.
34. Theret N, Lehti K, Musso O, Clement B. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 1999;30:462-468.
35. Benyon RC, Hovell CJ, Da Gaca M, Jones EH, Iredale JP, Arthur MJ. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 1999;30:977-986.
36. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992;24:193-203.
37. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999;117:1205-1221.
38. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A 1985;82:8681-8685.
39. Palmantier R, George MD, Akiyama SK, Wolber FM, Olden K, Roberts JD. Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu. Cancer Res 2001;61:2445-2452.
40. Pozzi A, Wary KK, Giancotti FG, Gardner HA. Integrin alphalbetal mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol 1998;142:587-594.
41. Kagami S, Kondo S, Loster K, Reutter W, Kuhara T, Yasutomo K, Kuroda Y. Alphalbetal integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-beta and platelet-derived growth factor-BB. J Am Soc Nephrol 1999;10:779-789.
42. Schocklmann HO, Lang S, Kralewski M, Hartner A, Ludke A, Sterzel RB. Distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney Int 2000;58:1108-1120.
43. Kostenuik PJ, Singh G, Orr FW. Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen. Clin Exp Metastasis 1997;15:41-52.
44. Eble JA, Beermann B, Hinz HJ, Schmidt-Hederich A. alpha2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem 2001;276:12274-12284.
45. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: Collagen type IV, laminin, and fibronectin. Gut 1980;21:63-71.
46. Cianfrocca M CT, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: A phase I AIDS malignancy consortium study. J Clin Oncol 2002;20:153-159.
47. Carney DE, McCann UG, Schiller HJ, Gatto LA, Steinberg J, Picone AL, Nieman GF. Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res 2001;99:245-252.
48. Rudek MA, Figg WD, Dyer V, Dahut W, Turner ML, Steinberg SM, Liewehr DJ, Kohler DR, Pluda JM, Reed E. Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer. J Clin Oncol 2001;19:584-592.
49. Maher JJ, Bissell DM. Cell-matrix interactions in liver. Semin Cell Biol 1993;4:189-201.
50. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999;29:140-148.
51. Seyer JM, Hutcheson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977;59:241-248.
52. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001;21:373-384.
53. Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol 2000;279:G245-G249.
54. Lohi J, Oivula J, Kivilaakso E, Kiviluoto T, Frojdman K, Yamada Y, Burgeson RE, Leivo I, Virtanen I. Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for alpha3betal integrin. APMIS 2000;108:161-172.
55. Edwards G, Streuli C. Signalling in extracellular-matrix-mediated control of epithelial cell phenotype. Biochem Soc Trans 1995;23:464-468.
56. Savin W, Dalmau SR, Dealmeida VC. Role of extracellular matrix-mediated interactions in thymocyte migration. Dev Immunol 2000;7:279-291.
57. Lafrenie RM, Yamada KM. Integrin-dependent signal transduction. J Cell Biochem 1996;61:543-553.
58. Rodan SB, Rodan GA. Integrin function in osteoclasts. J Endocrinol 1997;154(Suppl):S47-S56.
59. Lohi J, Leivo I, Oivula J, Lehto VP, Virtanen I. Extracellular matrix in renal cell carcinomas. Histol Histopathol 1998;13:785-796.
60. Friedl P, Brocker EB, Zanker KS. Integrins, cell matrix interactions and cell migration strategies: Fundamental differences in leukocytes and tumor cells. Cell Adhes Commun 1998;6:225-236.
61. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989;264:10756-10762.
62. Wei H, Lu H, Li D, Zhan Y, Wang Z, Huang X. The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCI4. Chin Med J (Engl) 2001;114:583-587.
63. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001;34:89-100.